Actively Recruiting

Age: 20Years - 45Years
FEMALE
NCT07494877

Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility

Led by Tang-Du Hospital · Updated on 2026-03-27

300

Participants Needed

1

Research Sites

121 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this prospective observational cohort study is to evaluate the effect of routine clinical anticoagulant therapy on endometrial receptivity and subsequent pregnancy outcomes in women with infertility. Researchers will utilize an ultrasound multimodal system to systematically assess endometrial parameters, including thickness, morphology, peristalsis, and blood flow indices. The study aims to enroll approximately 300 infertile women aged 20 to 45 years. Participants will be observed and grouped based on whether they receive anticoagulant medications, such as aspirin or heparin sodium, as part of their standard clinical care. The study will track ultrasound-based receptivity indicators and follow up on pregnancy status and outcomes at 45 and 90 days of gestation. This study is purely observational, and all clinical treatment decisions are made independently of the study protocol.

CONDITIONS

Official Title

Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility

Who Can Participate

Age: 20Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients aged 20 to 45 years
  • Diagnosed with infertility and planning embryo transfer or monitored conception cycles
  • Have complete baseline clinical data and agree to multimodal ultrasound evaluation during implantation window
  • Voluntarily agree to participate and signed informed consent for data collection
Not Eligible

You will not qualify if you...

  • Congenital uterine malformations that significantly alter the endometrial cavity
  • Untreated severe intrauterine lesions such as submucosal fibroids, severe adhesions, or endometrial polyps
  • Severe systemic diseases including serious liver or kidney dysfunction or malignant tumors
  • Known severe bleeding disorders or contraindications to anticoagulant medications
  • Unable to cooperate with transvaginal ultrasound or complete pregnancy follow-up

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tangdu Hospital, Air Force Medical University

Xi'an, Shaanxi, China, 710038

Actively Recruiting

Loading map...

Research Team

L

Li Zhang, MD

CONTACT

Z

Zhengjun Ma, MM

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here